Results 101 to 110 of about 17,734 (168)

Pharmacokinetics of dacarbazine (DTIC) in pregnancy.

, 2018
PURPOSE: The purpose of this report is to describe, for the first time, the pharmacokinetics of dacarbazine (DTIC) and its metabolites [5-[3-methyl-triazen-1-yl]-imidazole-4-carboxamide (MTIC), 5-[3-hydroxymethyl-3-methyl-triazen-1-yl]-imidazole-4 ...
Kantrowitz-Gordon, Ira, Reid, Joel M, Easterling, Thomas R, Ames, Matthew M, Hebert, Mary F, Kumar, Aditya R, Safgren, Stephanie L, Kayode, Olumide, Hays, Karen, Kaplan, Henry G   +9 more
core   +1 more source

Activity of irinotecan, cisplatin and dacarbazine (CPD) combination in previously treated patients with advanced colorectal carcinoma

, 2004
Aim: Irinotecan is an active drug after fluorouracil (FU) failure in patients with colorectal cancer (CRC). Also a modest activity of cisplatin and dacarbazine combination in FU resistant patients have been reported.
Icli, F, Buyukcelik, A, AKBULUT, HAKAN, DEMİRKAZIK, AHMET, Utkan, G, Yalcin, B, Onur, H   +6 more
core  

Innovative AC Electrospinning and Characterization of Nanofibers Comprised of Polyvinyl Alcohol and Dacarbazine for Solid State Drug Delivery of Cancer Therapeutic. [PDF]

Bionanoscience
Murphy RE, Yan Y, Parker J, Sen S, Brayer WA, Ning H.   +5 more
europepmc   +1 more source

Management Patterns and Outcomes for Relapsed or Refractory Hodgkin Lymphoma. [PDF]

J Hematol
Paniker AG, Marshalek JP, Chao E, Yashar D, Tomassetti S.   +4 more
europepmc   +1 more source

Treatment Outcomes of Advanced Stage Classical Hodgkin Lymphoma in the Setting of Vinblastine and Dacarbazine Shortages: A Case Series. [PDF]

Case Rep Oncol Med
Satyavarapu I, Giese N, Gandhi P, Umoru G, Burns EA, Pingali SR.   +5 more
europepmc   +1 more source

Classical Hodgkin Lymphoma Today. [PDF]

Mediterr J Hematol Infect Dis
D'Alò F, Schiaffini G, Mazzoni D, Alma E, Bellisario F, Viscovo M, Maiolo E, Bellesi S, Hohaus S.   +8 more
europepmc   +1 more source

Adriamycin, Vinblastine and Dacarbazine With Immunotherapy Achieves Complete Metabolic Response in a Patient With Classical Hodgkin Lymphoma and Dyskeratosis Congenita. [PDF]

J Hematol
Slapnicar C, Lala P, Lee S, Zandi S, Trinkaus M.   +4 more
europepmc   +1 more source

Promising effects of high-intensity focused ultrasound combined with eribulin and sintilimab in a patient with advanced leiomyosarcoma: a case report and literature review. [PDF]

Front Oncol
Li S, Jin M, Sun Q, Wang H, Hu X, Bai R, Dong Y.   +6 more
europepmc   +1 more source

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study. [PDF]

Br J Haematol
Porges T, Levi T, Dann EJ, Aumann S, Gurion R, Buchrits S, Perry C, Vitkon R, Levi I, Ilan E, Avigdor A, Marcus R, Harel R, Lahham N, Basood M, Filanovsky K, Dally N, Itchaki G, Sarid N, Benyamini N, Ben Barouch S, Tadmor T, Sofer O, Aboeid M, Strulovici A, Othman A, Kedmi M.   +26 more
europepmc   +1 more source

Aligning Estimands to Strengthen the Credibility of Network Meta-Analysis: Implications for Indirect Treatment Comparisons. [PDF]

Stat Biopharm Res
Xing X, Lin L, Tong J, He P, He W, Chu H.   +5 more
europepmc   +1 more source